We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment

By HospiMedica International staff writers
Posted on 18 May 2026

The Evala Nerve Stimulator from Epineuron (Mississauga, ON, Canada) is a handheld, intraoperative electrical stimulation system designed to provide surgeons with a rapid and accurate method for nerve identification and functional evaluation across different nerve sizes, both large and small. More...

The device has received U.S. Food and Drug Administration (FDA) 510(k) clearance. The clearance represents an expansion of the company’s portfolio and commercial footprint for its bioelectronic platform in peripheral nerve care.

Evala operates by delivering controlled electrical stimulation during surgery to help differentiate neural structures and assess functional responses in real time. The design emphasizes speed and accuracy to support intraoperative decision-making, including evaluation of both large and small-caliber nerves. Early clinical use scenarios cited for the system include revision procedures, nerve transfers, and cases performed under extended tourniquet time.

The company positions Evala as part of a broader ecosystem for peripheral nerve care, complementing its PeriPulse platform to support surgeons during the most demanding aspects of procedures. Within this portfolio approach, the technology is described as integrating into surgical workflows to enhance efficiency while addressing intraoperative nerve assessment needs.

“I am impressed with the versatility of the product allowing me to evaluate nerves in scarred revision surgeries, nerve transfers, under extended tourniquet time, and in conjunction with PeriPulse,” said Dr. Jana Dengler, MD, MASc, MHSc, peripheral nerve surgeon at Sunnybrook Health Sciences Centre.

“At Epineuron, we’ve listened closely to surgeons that expressed a significant need for more than just nerve stimulation hardware, they needed a cohesive ecosystem for nerve care," said Sergio Aguirre, CEO of Epineuron.

"We’ve broadened our technology by complementing PeriPulse® with Evala® to support surgeons during the most demanding aspects of a procedure. Whether it’s protecting nerves in real-time or boosting their regenerative capacity afterward, our technology integrates seamlessly into the surgical workflow to enhance efficiency and offer patients the best path to recovery,” said Aguirre.

Related Links
Epineuron


Gold Member
12-Channel ECG
CM1200B
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Tourniquet System
heidi– mein Tourniquet
New
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.